Virus-like particles (VLPs) are created by the self-assembly of multiple copies of envelope and/or capsid proteins from many viruses, mimicking the conformation of a native virus. Such noninfectious nanostructures are mainly used as antigen-presenting platforms, especially in vaccine research; however, some of them recently were used as scaffolds in biotechnology to produce targeted nanoparticles for intracellular delivery. This study demonstrates the creation of fusion VLPs using hepatitis B core protein-based system maintaining a fibronectin-binding property from B. burgdorferi BBK32 protein, including the evidence of particles' transmission to BHK-21 target cells via caveolae/rafts endocythosis. These results make this construct to be an attractive model in development of HBc-based nanoparticles for cellular targeting applications and highlights the fragment of B. burgdorferi BBK32 as a novel cellular uptake-promoting peptide.From the Clinical Editor: This paper discusses the nanotechnology-based application of self-assembling viral-like peptides (VLP-s) for targeted delivery using a hepatitis B core protein based system. Creating fusion VLPs may be an attractive model for cellular targeting applications. © 2013 Elsevier Inc. All rights reserved.Key words: Fibronectin; Nanoparticles; B. burgdorferi Various strategies in the design of nanoparticles (NPs) -particles in the size range 1 -1000 nm -aim to create new generations of drug-delivery vehicles, contrast agents, and diagnostic devices. 1 One of the relevant potentials of the nanomedicines is their intracellular targeting possibility. Effective intracellular drug delivery is important for therapeutic agents that have specific molecular targets inside a cell as well as for drugs that undergo extensive efflux from the cell by the efflux transporters. Thus, the ability to penetrate inside cells bypassing lysosomal degradation is one of the key problems in the rational design of pharmaceutical nanocarriers. 2 For this purpose, the surface of nanocarriers could be modified by certain internalizable ligands (e.g., folate, transferrin) or by cellpenetrating peptides, such as a trans-activating transcriptional activator (TaT), an integrin-binding peptide (RGD peptide) or polyArginine. 3 This approach is receiving increasing attention over the last years because it is efficient for a range of cell types, and various endocytotic mechanisms can be engaged to facilitate the internalization of a carrier. 2 Virus-like particles (VLPs) is a broad group of nanocarrier systems that exhibit great potential in biomedicine research, including targeted drug delivery. 4 VLPs are self-assembling noninfectious supramolecular structures that have been produced from structural proteins of a wide variety of virus families. The unique features of VLPs are proper dimensions for nanoscale applications, size homogeneity, a large surface area-to-mass ratio, a symmetric macromolecular organization, biodegradability, biocompatibility and ease of production/ purification. 5 In addit...